1. BrenchleyJM, SchackerTW, RuffLE, PriceDA, TaylorJH, et al. (2004) CD4+T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 200: 749–759.
2. SankaranS, GuadalupeM, ReayE, GeorgeMD, FlammJ, et al. (2005) Gut mucosal T cell responses and gene expression correlate with protection against disease in long-term HIV-1-infected nonprogressors. Proc Natl Acad Sci U S A 102: 9860–9865.
3. LiQ, DuanL, EstesJD, MaZM, RourkeT, et al. (2005) Peak SIV replication in resting memory CD4+T cells depletes gut lamina propria CD4+T cells. Nature 434: 1148–1152.
4. VeazeyRS, DeMariaM, ChalifouxLV, ShvetzD, PauleyD, et al. (1998) The gastrointestinal tract as a major site of CD4 T lymphocyte depletion and viral replication in SIV infection. Science 280: 427–431.
5. HaaseAT (2010) Targeting early infection to prevent HIV-1 mucosal transmission. Nature 464: 217–223.
6. MattapallilJJ, DouekDC, HillBJ, NishimuraY, MartinM, et al. (2005) Massive infection and loss of memory CD4+T cells in multiple tissues during acute SIV infection. Nature 434: 1093–1097.
7. VeazeyRS, ThamIC, MansfieldKG, DeMariaM, ForandAE, et al. (2000) Indentifying the target cell in primary simian immunodeficiency virus (SIV) infection: highly activated memory CD4+T cells are rapidly eliminated in early SIV infection in vivo. J Virol 74: 57–64.
8. SpitsH, CupedoT (2012) Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu Rev Immunol 30: 647–675.
9. SpitsH, Di SantoJP (2011) The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat Immunol 12: 21–27.
10. Satoh-TakayamaN, VosshenrichCA, Lesjean-PottierS, SawaS, LochnerM, et al. (2008) Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 29: 958–970.
11. SonnenbergGF, MonticelliLA, EllosoMM, FouserLA, ArtisD (2011) CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut. Immunity 34: 122–134.
12. ZhengY, ValdezPA, DanilenkoDM, HuY, SaSM, et al. (2008) Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 14: 282–289.
13. MoroK, YamadaT, TanabeM, TakeuchiT, IkawaT, et al. (2010) Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 463: 540–544.
14. BoosMD, YokotaY, EberlG, KeeBL (2007) Mature natural killer cell and lymphoid tissue-inducing cell development requires Id2-mediated suppression of E protein activity. J Exp Med 204: 1119–1130.
15. SchmutzS, BoscoN, ChappazS, BoymanO, Acha-OrbeaH, et al. (2009) Cutting edge: IL-7 regulates the peripheral pool of adult ROR gamma+ lymphoid tissue inducer cells. J Immunol 183: 2217–2221.
16. Satoh-TakayamaN, Lesjean-PottierS, VieiraP, SawaS, EberlG, et al. (2010) IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46+ cell subsets from Id2-dependent precursors. J Exp Med 207: 273–280.
17. GordonSM, ChaixJ, RuppLJ, WuJ, MaderaS, et al. (2012) The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation. Immunity 36: 55–67.
18. CellaM, FuchsA, VermiW, FacchettiF, OteroK, et al. (2009) A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457: 722–725.
19. TakatoriH, KannoY, WatfordWT, TatoCM, WeissG, et al. (2009) Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J Exp Med 206: 35–41.
20. SpitsH, ArtisD, ColonnaM, DiefenbachA, Di SantoJP, et al. (2013) Innate lymphoid cells—a proposal for uniform nomenclature. Nat Rev Immunol 13: 145–149.
21. HoylerT, KloseCS, SouabniA, Turqueti-NevesA, PfeiferD, et al. (2012) The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity 37: 634–648.
22. MjosbergJ, BerninkJ, GolebskiK, KarrichJJ, PetersCP, et al. (2012) The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells. Immunity 37: 649–659.
23. ReevesRK, RajakumarPA, EvansTI, ConnoleM, GillisJ, et al. (2011) Gut inflammation and indoleamine deoxygenase inhibit IL-17 production and promote cytotoxic potential in NKp44+ mucosal NK cells during SIV infection. Blood 118: 3321–3330.
24. XuH, WangX, LiuDX, Moroney-RasmussenT, LacknerAA, et al. (2012) IL-17-producing innate lymphoid cells are restricted to mucosal tissues and are depleted in SIV-infected macaques. Mucosal Immunol 5: 658–669.
25. KlattNR, EstesJD, SunX, OrtizAM, BarberJS, et al. (2012) Loss of mucosal CD103+ DCs and IL-17+ and IL-22+ lymphocytes is associated with mucosal damage in SIV infection. Mucosal Immunol 5: 646–657.
26. KhowawisetsutL, PattanapanyasatK, OnlamoonN, MayneAE, LittleDM, et al. (2013) Relationships between IL-17(+) subsets, Tregs and pDCs that distinguish among SIV infected elite controllers, low, medium and high viral load rhesus macaques. PLoS One 8: e61264.
27. LiyanageNP, GordonSN, DosterMN, PeguP, VaccariM, et al. (2014) Antiretroviral therapy partly reverses the systemic and mucosal distribution of NK cell subsets that is altered by SIVmac(2)(5)(1) infection of macaques. Virology 450–451: 359–368.
28. Scott-AlgaraD, TruongLX, VersmisseP, DavidA, LuongTT, et al. (2003) Cutting edge: increased NK cell activity in HIV-1-exposed but uninfected Vietnamese intravascular drug users. J Immunol 171: 5663–5667.
29. TomescuC, DuhFM, HohR, VivianiA, HarvillK, et al. (2012) Impact of protective killer inhibitory receptor/human leukocyte antigen genotypes on natural killer cell and T-cell function in HIV-1-infected controllers. AIDS 26: 1869–1878.
30. PancinoG, Saez-CirionA, Scott-AlgaraD, PaulP (2010) Natural resistance to HIV infection: lessons learned from HIV-exposed uninfected individuals. J Infect Dis 202 Suppl 3S345–350.
31. TomescuC, DuhFM, LanierMA, KapalkoA, MounzerKC, et al. (2010) Increased plasmacytoid dendritic cell maturation and natural killer cell activation in HIV-1 exposed, uninfected intravenous drug users. AIDS 24: 2151–2160.
32. RavetS, Scott-AlgaraD, BonnetE, TranHK, TranT, et al. (2007) Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals. Blood 109: 4296–4305.
33. Flores-VillanuevaPO, YunisEJ, DelgadoJC, VittinghoffE, BuchbinderS, et al. (2001) Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity. Proc Natl Acad Sci U S A 98: 5140–5145.
34. AlterG, MartinMP, TeigenN, CarrWH, SuscovichTJ, et al. (2007) Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J Exp Med 204: 3027–3036.
35. O'ConnellKA, HanY, WilliamsTM, SilicianoRF, BlanksonJN (2009) Role of natural killer cells in a cohort of elite suppressors: low frequency of the protective KIR3DS1 allele and limited inhibition of human immunodeficiency virus type 1 replication in vitro. J Virol 83: 5028–5034.
36. ElemansM, ThiebautR, KaurA, AsquithB (2011) Quantification of the relative importance of CTL, B cell, NK cell, and target cell limitation in the control of primary SIV-infection. PLoS Comput Biol 7: e1001103.
37. ReevesRK, GillisJ, WongFE, YuY, ConnoleM, et al. (2010) CD16- natural killer cells: enrichment in mucosal and secondary lymphoid tissues and altered function during chronic SIV infection. Blood 115: 4439–4446.
38. Abdel-MotalUM, GillisJ, MansonK, WyandM, MontefioriD, et al. (2005) Kinetics of expansion of SIV Gag-specific CD8+T lymphocytes following challenge of vaccinated macaques. Virology 333: 226–238.
39. ReevesRK, GillisJ, WongFE, JohnsonRP (2009) Vaccination with SIVmac239Deltanef activates CD4+T cells in the absence of CD4 T-cell loss. J Med Primatol 38 Suppl 18–16.
40. GiavedoniLD (2005) Simultaneous detection of multiple cytokines and chemokines from nonhuman primates using luminex technology. Journal of Immunological Methods 301: 89–101.
41. ClineAN, BessJW, PiatakMJr, LifsonJD (2005) Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS. J Med Primatol 34: 303–312.
42. HansenSG, PiatakMJr, VenturaAB, HughesCM, GilbrideRM, et al. (2013) Immune clearance of highly pathogenic SIV infection. Nature 502: 100–104.
43. ReevesRK, EvansTI, GillisJ, JohnsonRP (2010) Simian immunodeficiency virus infection induces expansion of alpha4beta7+ and cytotoxic CD56+ NK cells. J Virol 84: 8959–8963.
44. ReevesRK, EvansTI, GillisJ, WongFE, KangG, et al. (2012) SIV infection induces accumulation of plasmacytoid dendritic cells in the gut mucosa. J Infect Dis 206: 1462–1468.
45. EstesJD, HarrisLD, KlattNR, TabbB, PittalugaS, et al. (2010) Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS Pathog 6. DOI:10.1371/journal.ppat.1001052
46. KlattNR, FunderburgNT, BrenchleyJM (2013) Microbial translocation, immune activation, and HIV disease. Trends Microbiol 21: 6–13.
47. MorthaA, ChudnovskiyA, HashimotoD, BogunovicM, SpencerSP, et al. (2014) Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis. Science 343: 1249288.
48. KloseCS, KissEA, SchwierzeckV, EbertK, HoylerT, et al. (2013) A T-bet gradient controls the fate and function of CCR6-RORgammat+ innate lymphoid cells. Nature 494: 261–265.
49. BuonocoreS, AhernPP, UhligHH, Ivanov, II, LittmanDR, et al. (2010) Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 464: 1371–1375.
50. FuchsA, ColonnaM (2013) Innate lymphoid cells in homeostasis, infection, chronic inflammation and tumors of the gastrointestinal tract. Curr Opin Gastroenterol 29: 581–587.
51. AlterG, TeigenN, DavisBT, AddoMM, SuscovichTJ, et al. (2005) Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection. Blood 106: 3366–3369.
52. AlterG, TeigenN, AhernR, StreeckH, MeierA, et al. (2007) Evolution of innate and adaptive effector cell functions during acute HIV-1 infection. J Infect Dis 195: 1452–1460.
53. ChoiEI, ReimannKA, LetvinNL (2008) In vivo natural killer cell depletion during primary simian immunodeficiency virus infection in rhesus monkeys. Journal of Virology 82: 6758–6761.
54. ChoiEI, WangR, PetersonL, LetvinNL, ReimannKA (2008) Use of an anti-CD16 antibody for in vivo depletion of natural killer cells in rhesus macaques. Immunology 124: 215–222.
55. FehnigerTA, HerbeinG, YuH, ParaMI, BernsteinZP, et al. (1998) Natural killer cells from HIV-1+ patients produce C-C chemokines and inhibit HIV-1 infection. J Immunol 161: 6433–6438.
56. O'ConnorGM, HolmesA, MulcahyF, GardinerCM (2007) Natural killer cells from long-term non-progressor HIV patients are characterized by altered phenotype and function. Clin Immunol 124: 277–283.
57. GiavedoniLD, VelasquilloMC, ParodiLM, HubbardGB, HodaraVL (2000) Cytokine expression, natural killer cell activation, and phenotypic changes in lymphoid cells from rhesus macaques during acute infection with pathogenic simian immunodeficiency virus. J Virol 74: 1648–1657.
58. ShiehTM, CarterDL, BlosserRL, MankowskiJL, ZinkMC, et al. (2001) Functional analyses of natural killer cells in macaques infected with neurovirulent simian immunodeficiency virus. J Neurovirol 7: 11–24.
59. BostikP, KobkitjaroenJ, TangW, VillingerF, PereiraLE, et al. (2009) Decreased NK cell frequency and function is associated with increased risk of KIR3DL allele polymorphism in simian immunodeficiency virus-infected rhesus macaques with high viral loads. J Immunol 182: 3638–3649.
60. GonzalezVD, FalconerK, MichaelssonJ, MollM, ReichardO, et al. (2008) Expansion of CD56- NK cells in chronic HCV/HIV-1 co-infection: reversion by antiviral treatment with pegylated IFNalpha and ribavirin. Clin Immunol 128: 46–56.
61. MarrasF, NiccoE, BozzanoF, Di BiagioA, DentoneC, et al. (2013) Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulation. Proc Natl Acad Sci U S A 110: 11970–11975.
62. MichaelssonJ, LongBR, LooCP, LanierLL, SpottsG, et al. (2008) Immune reconstitution of CD56(dim) NK cells in individuals with primary HIV-1 infection treated with interleukin-2. J Infect Dis 197: 117–125.
63. KamyaP, BouletS, TsoukasCM, RoutyJP, ThomasR, et al. (2011) Receptor-ligand requirements for increased NK cell polyfunctional potential in slow progressors infected with HIV-1 coexpressing KIR3DL1*h/*y and HLA-B*57. J Virol 85: 5949–5960.